Mikronizované Flavonoidy (Diosmin)

Diosmin acts as a venotonic agent. It increases the contractility of venous smooth muscle, lowers venous capacitance, and promotes lymphatic drainage. By stabilising capillary permeability, it improves microcirculation and reduces edema in the affected vascular beds.

The dosage of Mikronizované Flavonoidy is determined by the prescribing healthcare professional based on the individual’s condition, severity and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety data for diosmin in pregnancy and lactation are limited. It is classified as a precautionary medication, and use should only be considered if the potential benefit justifies any possible risk. Consultation with a qualified healthcare provider is essential before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Mikronizované Flavonoidy (diosmin) is comparable to other flavonoid‑based agents such as hesperidin or horse‑chestnut extract. Diosmin offers a well‑studied venotonic profile with a favorable safety record, while combination products may provide additional synergistic effects. Choice of therapy depends on clinical judgment, patient tolerance and regional guidelines.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging to protect it from moisture and light. Do not expose the tablets or granules to excessive heat or humidity, and keep them out of reach of children.

Mikronizované Flavonoidy is taken orally, usually with a glass of water. It can be taken with or without food, unless the prescriber advises otherwise. Swallow the tablets or granules whole; do not crush or chew unless specifically instructed.

Serious adverse reactions, although rare, include severe allergic responses such as rash, swelling or breathing difficulty, hepatic dysfunction manifested by elevated liver enzymes or jaundice, and thrombocytopenia leading to abnormal bleeding. Patients should seek immediate medical attention if any of these symptoms develop.

Individuals with known hypersensitivity to diosmin or other flavonoids should avoid the product. It is also contraindicated in patients with severe liver disease, uncontrolled bleeding disorders, or those who are pregnant or breastfeeding unless the prescriber determines that the benefits outweigh the risks.